5/23

Matthew and I had a zoom call with Mr. David Ungaro, our mentor for this internship, to discuss the expectations of our internship and what we would be doing over the next two weeks. I had the opportunity to discuss where my interest in computer science started with him, and explain why I wanted to intern at Gilead sciences. We talked about what the focus of our work would be, and that we had a lot of freedom in terms of what we wanted to work on.

I also researched the location, and apparently their building in NC is relatively new, built within the last year.

5/24

 

 

Image previewThe Data Science Process - KDnuggets

Today was really busy, as we learned first about the basics of data science and then completed a small project. It was our first time in the office, so it was really cool to work in the modern buildings at Northills, especially with the wide windowed conference rooms. We were taught in the morning about the process of data analytics and met Gilead Sciences’s CIO (Chief information officer). Since both of us had no prior experience to data analytics, it was an eye-opening experience to see how companies have entire departments dedicated to the collection and analysis of data. After getting lunch at a restaurant elsewhere in Northills, we were given our first project of analyzing vaccination data across the world. We organized WHO website data using excel functions for the rest of the afternoon and will present our results tomorrow. We heard that tomorrow we’ll be doing more programming and advanced data analytics tomorrow, so we’re pretty excited about it.

5/23

Evan and I met with our mentor, David Ungaro, today to plan out the rest of our WEP and to schedule coming into the office tomorrow. David also explained more about what Gilead Science stands for and the status of the office. It turns out that this building was built less than a year ago in Northills, and they’re actually having the opening party next week. His work consists of taking data from pharmaceutical manufacturing lines and finding ways that the processes can be improved. From our conversation, it seems like our work in the next two weeks will depend a lot on what we find most interesting, and we’ll look more into that tomorrow. Either way, I’m excited to see what we learn from this experience.

Gilead Sciences First Post

Gilead Sciences, Inc.For the next two weeks, I will be working with Gilead Sciences, a worldwide pharmaceutical firm known for its groundbreaking Hepatitis C and HIV drugs. They’re also starting to work more in the cancer sector, with over a dozen clinical trials in the pipeline. Although I don’t know all the details yet, I have heard that Evan and I will work on a project of some kind for a large portion of the WEP, as well as working in their Raleigh office.

Matthew

Skip to toolbar